Organophosphorus poisoning can occur when one is exposed to organophosphates for too long or at high levels. Organophosphates are a common type of insecticide. However, high levels of organophosphates can be harmful to humans and other animals.
Organophosphates are useful as pharmaceuticals, pesticides, and as nerve agents. Due to the extensive usage of these chemicals in agriculture, the majority of organophosphate toxicity cases presently involve farmers and other individuals who function in this field.
Organophosphate molecules can penetrate the body through the skin, by inhalation, or through the digestive system
The molecule permeates red blood cells where it binds to an acetylcholinesterase molecule, making the enzyme inactive
This causes synapses and neuromuscular junctions to accumulate an excess of acetylcholine
Myoclonic jerks and fasciculations can occur as a result of the overstimulation of nicotinic receptors at neuromuscular junctions
The depolarizing blockage ultimately results in flaccid paralysis
The adrenal glands have nicotinic receptors, which can lead to hypertension, perspiration, tachycardia, and leukocytosis with a left shift
The effects of organophosphate poisoning on muscarinic receptors result in additional symptoms
G-protein-coupled receptors are responsible for these effects, which are typically slower than those of nicotinic receptors
Organophosphate toxicity has parasympathetic effects on several systems, including the heart, exocrine glands, and smooth muscles
Symptoms range from mild to moderate depending on the exposure to organophosphates, they include:
Mild organophosphate exposure results in:
Moderate organophosphate exposure results in:
Organophosphate poisoning can lead to several significant consequences. These are some examples:
1.
Stem Cell Selection Unneeded for SSc Transplant Therapy?
2.
Lung Transplant for Lung Cancer: Promising, in Rare Cases
3.
Rural-urban disparities seen in cervical cancer
4.
Obesity linked to subsequent neoplasms in childhood cancer survivors
5.
New policy review highlights the importance of health-related quality of life in advanced cancer
1.
Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights
2.
Transplant Oncology and Anti-Cancer Immunosuppressants: The Evolution of a Paradigm in Cancer Care
3.
Is AI The New Radiologist For Breast MRI?
4.
Pediatric Oncology at the Cutting Edge: From Early Diagnosis to Lifesaving Therapies
5.
Bone Marrow Regeneration in Hematologic Recovery
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Navigating the Complexities of Ph Negative ALL - Part VI
2.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
4.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
5.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation